CRINETICS PHARMACEUTICALS IN insider transactions

CRINETICS PHARMACEUTICALS IN insider transactions
DatePersonTitleTypeNameSharesShares (Total)PriceCode
2024-04-18Struthers Richard ScottSellCommon Stock-350.0257,485$0.0G
2024-04-15Pizzuti DanaBuyCommon Stock14375.042,161$16.9M
2024-04-15Pizzuti DanaSellStock option (Right to Buy)-14375.0177,292$0.0M
2024-04-15Struthers Richard ScottSellStock Option (Right to Buy)-20000.081,270$0.0M
2024-04-15Struthers Richard ScottBuyCommon Stock20000.0257,835$1.9M
2024-04-15Pizzuti DanaSellCommon Stock-14375.027,786$44.5S
2024-04-04Struthers Richard ScottBuyCommon Stock40951.0278,786$9.3M
2024-04-04Struthers Richard ScottSellNon-qualified stock option (Right to Buy)-40951.0123,790$0.0M
2024-04-04Struthers Richard ScottSellCommon Stock-40951.0237,835$49.2S
2024-03-28Okey StephanieBuyStock Option (right to buy)17500.00$0.0M
2024-03-28Okey StephanieBuyCommon Stock17500.023,500$18.3M
2024-03-28Okey StephanieSellCommon Stock-17500.06,000$46.4S
2024-03-22Knight Jeff E.BuyCommon Stock30000.084,939$24.0M
2024-03-22Knight Jeff E.SellStock Option (right to buy)-30000.0130,000$0.0M
2024-03-22Knight Jeff E.SellCommon Stock-2359.052,580$45.4S
2024-03-22Knight Jeff E.SellCommon Stock-30000.054,939$44.2S
2024-03-20Fust Matthew KSellCommon Stock-12500.018,536$43.6S
2024-03-20Fust Matthew KSellCommon Stock-12500.018,536$43.6S
2024-03-20Fust Matthew KBuyCommon Stock12500.031,036$23.2M
2024-03-20Fust Matthew KBuyCommon Stock12500.031,036$23.2M